Inflammatory Eye Disease Awareness Week
Prevent Blindness has declared September 16–22, 2024, as Inflammatory Eye Disease Awareness Week. There are several inflammatory eye conditions. The one we specialize in at Texas Retina is called uveitis [u-vee-i-tis]. Understanding
read more
Dr. Abbey Presented Real-world Outcomes of Fluocinolone Acetonide Intravitreal Implant for Non-infectious Uveitis at ASRS 2024 Annual Meeting
Texas Retina’s Ashkan M. Abbey, MD, presented “36-month Optical Coherence Tomography Outcomes from CALM: A Registry Evaluating Treatment of Chronic Non-infectious Uveitis with the 0.18 mg Fluocinolone Acetonide Intravitreal Implant” at the
read more
New Clinical Trials at Texas Retina
Over the past two decades, Texas Retina physicians have participated in more than 100 national clinical trials, offering our patients access to promising new treatments for a variety of retina conditions, including
read more
Dr. Wang’s Research Published in British Journal of Ophthalmology
Texas Retina Associates’ Robert C. Wang, MD, co-authored an article titled “Extension Study of the Safety and Efficacy of CLS-TA for Treatment of Macular Edema Associated with Non-infectious Uveitis (MAGNOLIA)” in the
read more
Dr. Wang Published Article on Long-term Inflammation Control and Uveitis in Retina Today
Texas Retina Associates’ Robert C. Wang, MD, shared three case studies in an article titled “Long-term Inflammation Control Benefits All Types of Uveitis” published in the November/December 2020 issue of the medical
read more